A detailed history of Fuller & Thaler Asset Management, Inc. transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Fuller & Thaler Asset Management, Inc. holds 456,522 shares of TMDX stock, worth $36.9 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares
456,522
Previous 396,330 15.19%
Holding current value
$36.9 Million
Previous $59.7 Million 20.07%
% of portfolio
0.29%
Previous 0.26%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$135.68 - $176.11 $8.17 Million - $10.6 Million
60,192 Added 15.19%
456,522 $71.7 Million
Q2 2024

Aug 09, 2024

BUY
$72.62 - $150.62 $6.78 Million - $14.1 Million
93,323 Added 30.8%
396,330 $59.7 Million
Q1 2024

May 13, 2024

BUY
$70.86 - $89.93 $21.5 Million - $27.2 Million
303,007 New
303,007 $22.4 Million

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $2.58B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track Fuller & Thaler Asset Management, Inc. Portfolio

Follow Fuller & Thaler Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fuller & Thaler Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Fuller & Thaler Asset Management, Inc. with notifications on news.